Literature DB >> 32755585

ATF4 Regulates MYB to Increase γ-Globin in Response to Loss of β-Globin.

Mandy Y Boontanrart1, Markus S Schröder2, Gautier M Stehli2, Marija Banović2, Stacia K Wyman3, Rachel J Lew1, Matteo Bordi2, Benjamin G Gowen1, Mark A DeWitt1, Jacob E Corn4.   

Abstract

β-Hemoglobinopathies can trigger rapid production of red blood cells in a process known as stress erythropoiesis. Cellular stress prompts differentiating erythroid precursors to express high levels of fetal γ-globin. However, the mechanisms underlying γ-globin production during cellular stress are still poorly defined. Here, we use CRISPR-Cas genome editing to model the stress caused by reduced levels of adult β-globin. We find that decreased β-globin is sufficient to induce robust re-expression of γ-globin, and RNA sequencing (RNA-seq) of differentiating isogenic erythroid precursors implicates ATF4 as a causal regulator of this response. ATF4 binds within the HBS1L-MYB intergenic enhancer and regulates expression of MYB, a known γ-globin regulator. Overall, the reduction of ATF4 upon β-globin knockout decreases the levels of MYB and BCL11A. Identification of ATF4 as a key regulator of globin compensation adds mechanistic insight to the poorly understood phenomenon of stress-induced globin compensation and could inform strategies to treat hemoglobinopathies.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BCL11A; CRISPR/Cas9; Fetal hemoglobin; HBS1L-MYB; adult hemoglobin; gene editing; hemoglobinopathies; stress erythropoiesis

Mesh:

Substances:

Year:  2020        PMID: 32755585     DOI: 10.1016/j.celrep.2020.107993

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  5 in total

Review 1.  Translational control by heme-regulated elF2α kinase during erythropoiesis.

Authors:  Jane-Jane Chen; Shuping Zhang
Journal:  Curr Opin Hematol       Date:  2022-01-21       Impact factor: 3.218

2.  Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity.

Authors:  Eric Alves; Emily McLeish; Pilar Blancafort; Jerome D Coudert; Silvana Gaudieri
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

3.  High-level correction of the sickle mutation is amplified in vivo during erythroid differentiation.

Authors:  Wendy Magis; Mark A DeWitt; Stacia K Wyman; Jonathan T Vu; Seok-Jin Heo; Shirley J Shao; Finn Hennig; Zulema G Romero; Beatriz Campo-Fernandez; Suzanne Said; Matthew S McNeill; Garrett R Rettig; Yongming Sun; Yu Wang; Mark A Behlke; Donald B Kohn; Dario Boffelli; Mark C Walters; Jacob E Corn; David I K Martin
Journal:  iScience       Date:  2022-05-10

Review 4.  Cellular Basis of Embryonic Hematopoiesis and Its Implications in Prenatal Erythropoiesis.

Authors:  Toshiyuki Yamane
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923

5.  Multi-Omics Analysis in β-Thalassemia Using an HBB Gene-Knockout Human Erythroid Progenitor Cell Model.

Authors:  Guoqiang Zhou; Haokun Zhang; Anning Lin; Zhen Wu; Ting Li; Xumin Zhang; Hongyan Chen; Daru Lu
Journal:  Int J Mol Sci       Date:  2022-03-04       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.